
Biologic and targeted therapy begin with understanding the disease at a deeper level. These medicines are not chosen casually. They are prescribed when the diagnosis, disease pattern, and previous response to treatment suggest that a more specific approach is needed. In rheumatology, that often means conditions such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, vasculitis, and other autoimmune disorders.
Biologics, including TNF inhibitors, IL-6 inhibitors, and IL-17 inhibitors, work by interrupting inflammatory signals that keep the immune system overactive. JAK inhibitors act inside the cell to block pathways that fuel inflammation. Rituximab therapy is used when B-cell activity needs to be reduced, while cyclophosphamide protocols are reserved for more severe or organ-threatening disease patterns. In some situations, pulse steroid therapy is used alongside these medicines to bring inflammation under faster control.
Treatment may be given as tablets, injections, or infusions, depending on the drug and the disease. Patients receiving IV biologics or infusion-based therapy are monitored carefully before, during, and after administration. Blood tests, screening for infection, and regular follow-up help the team adjust treatment safely. The aim is not just to suppress disease but to control it with enough precision to protect long-term function.
For patients with severe autoimmune disease, biologic and targeted therapies offer the possibility of remission where conventional treatments have failed. Key benefits include the following:
More precise control of autoimmune and inflammatory disease
Reduced flare frequency and improved day-to-day comfort
Treatment options beyond standard pain relief or conventional medicine
Careful monitoring to support safer long-term use
A personalised plan matched to disease severity and response
From the first consultation to ongoing follow-up, the process is structured to make treatment clear rather than overwhelming. These medicines can be powerful, but they work best when patients understand what is being done and why.
Initial Assessment
Your doctor reviews your symptoms, diagnosis, prior medications, blood tests, and imaging before deciding whether biologic or targeted therapy is the right step. In many cases, treatment is started only after confirming that the infection and other risks have been considered.
Treatment Planning
Once a medicine is chosen, the team explains how it is given, how often it is needed, and what monitoring is required. Some therapies are delivered as tablets at home, while others are arranged through infusion-based care.
During Treatment
For infusion or injection-based medicines, the patient is monitored for comfort and early reactions. The process is usually calm and controlled, with nursing staff observing vital signs and any immediate side effects.
Ongoing Monitoring
Follow-up is an important part of the journey. Blood counts, liver and kidney tests, inflammatory markers, and infection screening may be repeated to track safety and response.
Adjustment and Continuity
If the disease settles, the treatment may continue. If the response is incomplete, the plan may be adjusted. The focus stays on long-term disease control, not just short-term symptom relief.
Autoimmune and inflammatory diseases are rarely managed effectively with a single, uniform approach. They need careful diagnosis, regular reassessment, and treatment decisions that respond to the patient’s actual disease pattern. At Manipal Hospital Kanakapura Road, we handle that work through specialist-led care, structured monitoring, and a treatment environment built around safety and continuity. For patients seeking targeted therapy in Kanakapura Road, the difference lies in the thoughtful planning of each step. You can understand the value we provide through these core components of our practice:
Rheumatology specialists who select therapy based on disease type, severity, and prior response
Close monitoring for infusion reactions, lab changes, and treatment tolerance
Coordinated care for medicines such as biologics, JAK inhibitors, rituximab, and cyclophosphamide
Clear patient counselling so treatment feels understandable, not intimidating
Follow-up planning that supports long-term disease control and daily function
Access to a full range of biologic agents, including infliximab, adalimumab, etanercept, tocilizumab, secukinumab, ustekinumab, and rituximab
Integration with physiotherapy and rehabilitation to ensure that improvements in disease activity translate into improvements in function and quality of life
The Rheumatology department focuses on autoimmune, inflammatory, and joint-related conditions that often need long-term medical management. From early arthritis to more complex systemic disease, the team uses detailed evaluation, targeted therapy, and close follow-up to reduce inflammation, protect organs, and preserve movement and quality of life.
Our biologic and targeted therapy services include TNF inhibitors (infliximab, adalimumab, etanercept, certolizumab, golimumab), IL‑6 inhibitors (tocilizumab), IL‑17 inhibitors (secukinumab, ixekizumab), IL‑23 inhibitors (ustekinumab, guselkumab), JAK inhibitors (tofacitinib, upadacitinib, baricitinib), rituximab therapy for rheumatoid arthritis and vasculitis, and cyclophosphamide protocols for lupus nephritis and vasculitis. All infusions are delivered in a dedicated day-care suite with specialised nursing support.
Treatment works best when the setting is built for it. For patients receiving IV biologics in Kanakapura Road, the care environment at Manipal Hospital Kanakapura Road is designed to make therapy safer, smoother, and more predictable. Our facilities include:
A dedicated Day-Care Infusion Suite for scheduled biologic and infusion-based treatments
Nursing supervision during infusions, with vital sign checks before, during, and after administration
Pre-treatment screening for infection risk, blood counts, liver function, and treatment suitability
Access to rituximab infusions, cyclophosphamide infusions, and pulse steroid therapy when clinically indicated
Care pathways for biologics, including TNF inhibitors, IL-6 inhibitors, IL-17 inhibitors, and other targeted agents
A structured approach to monitoring side effects, treatment response, and long-term disease control
Pharmacy and clinical coordination so medicine scheduling, follow-up, and documentation stay organised
Escalation support for patients who need treatment changes, additional testing, or closer observation
These services help the team deliver therapy in a way that is clinically precise and practical for the patient’s routine.
These medicines are usually considered when an inflammatory disease remains active despite standard treatment or when the condition is severe enough to need more specific immune control. The decision depends on diagnosis, symptoms, and test results.
It can be either. Some targeted medicines are taken orally, while others are given by injection or infusion. Your doctor decides the route based on the drug, the disease, and how closely it needs to be monitored.
Before treatment, the team usually checks blood tests, infection screening, and treatment history. A nurse or doctor then confirms the medicine, reviews symptoms, and watches for any early reaction once the infusion begins.
It targets the immune process driving the disease instead of only easing pain. That makes it more disease-focused, especially when joint swelling, stiffness, or inflammation keeps returning despite simpler medicines.
Yes. Follow-up is essential because these medicines need monitoring for safety and effectiveness. Your doctor may repeat blood tests, review symptoms, and adjust treatment if the response changes over time.
Home Kanakapuraroad Specialities Rheumatology Biologic-targeted-therapy
Visit the Global site for International patient services